MolNFT v1 · #64696 · protein
GSK3BETA inhibitor complex
3GB2 · Glycogen synthase kinase-3 beta: “GSK3BETA inhibitor complex”. X-ray diffraction, 1 ligand (G3B), 4 pockets (best druggability 0.61). MolNFT v1 #64696 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 3GB2
- Type
- protein
- Length
- 341 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Glycogen synthase kinase-3 beta
- EC
- 2.7.11.26
- UniProt
- P49841
- Ligands
- G3B
- Pockets
- 4 · best druggability 0.61
Structure
x-ray diffraction · 1 distinct chain · 33% helix, 18% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Glycogen synthase kinase-3 beta (EC 2.7.11.26) | protein | 341 | 33% helix, 18% strand | P49841 |
Ligands and binding sites
- G3B · 2-methyl-5-(3-{4-[(S)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 243 | 0.61 | 0.80 | 28 | G3B |
| 2 | 52 | 0.38 | 0.81 | 20 | empty |
| 3 | 75 | 0.31 | 0.74 | 16 | empty |
| 4 | 65 | 0.27 | 0.73 | 16 | empty |
Modifications
Observed in the structure: 1 modified (phosphorylation).
Compared structures
- 3GB2 · GSK3beta inhibitor complex · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P49841
- Elsewhere: RCSB PDB 3GB2 · PDBe 3GB2 · UniProt P49841
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.